AcuityMD vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
AcuityMD is the MedTech commercial intelligence platform trusted by nearly 500 companies including 8 of the top 10; raised $163M total including an $80M Series C; named to Forbes' 2025 Next Billion-Dollar Startups list;
About
AcuityMD is a Boston-based software company founded in 2018 that builds AI-powered commercial intelligence tools specifically for the medical technology (MedTech) industry. The platform provides medical device sales teams with a unified view of market data, physician and facility targeting, claims analytics, and CRM-integrated workflows — enabling them to identify the highest-value opportunities, forecast sales performance, and prioritize outreach with AI-generated next-best actions. AcuityMD draws on a dataset encompassing more than 330 million patients from an all-payor claims dataset built in partnership with CMS and major claims aggregators.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.